-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Downgrades Bio-Techne to Sector Perform, Raises Price Target to $73

Benzinga·07/09/2026 15:21:01
Listen to the news
RBC Capital analyst Dan Leonard downgrades Bio-Techne (NASDAQ:TECH) from Outperform to Sector Perform and raises the price target from $62 to $73.